Posted inPress Releases
China Expands Oncology Treatment Options With New Cancer Chemotherapy Approvals
China’s oncology market is entering another phase of competition as regulators approve new treatment combinations for lung and breast cancer. The latest decisions cover Akeso’s ivonescimab in combination with chemotherapy…









